Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02147041Phase 3Unknown
Phase 3, randomised, double-blind trial (2 arms), sponsored by Taipei City Hospital. Primary endpoint: composite of anthropometric measures at 12 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02147041.